Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Impact of NMES on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension

14. november 2019 oppdatert av: Profa. Dra. Vera Lúcia dos Santos Alves, Faculdade de Ciências Médicas da Santa Casa de São Paulo

Impact of Peripheral Neuromuscular Electrical Stimulation on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension

Pulmonary hypertension (PH) features symptoms related to a decreased cardiac autonomic response, pulmonary function and exercise capacity.

Non-pharmacological interventions are low cost and can significant enhance outcomes in these patients. Neuromuscular electrical stimulation (NMES) has been proposed as a viable therapeutic approach in patients with functional limitations, particularly those that present with difficulty to perform exercise protocols.

Objective: to evaluate the impact of NMES on exercise capacity, spirometry values and quality of life of patients with PH.

Material and methods: prospective randomized controlled study with a control group (GC, n9) and NMES goup (GE, n8). Quality of life and exercise capacity through the six-minute walk test (6MWT) were assessed before and after the NMES protocol.

Results: the GE presented with a significant improvement in distance walked in the 6MWT, cycle ergometry, spirometry and quality of life in the areas of vitality, emotional and social aspects of the questionnaire Short Form Health Survey-36.

Conclusion: NMES is a useful tool in the treatment of patients with PH, resulting in improved exercise capacity, quality of life and lung function testing.

Studieoversikt

Status

Fullført

Studietype

Intervensjonell

Registrering (Faktiske)

30

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Sao Paulo, Brasil, 01221-020
        • Santa Casa of Sao Paulo Medical School

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 80 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

Males and females greater than or equal to 18 years of age, clinically stable with optimized drug therapy in the last 3 months, previously diagnosed with a mean pulmonary arterial pressure ≥ 25 mmHg by right heart catheterization and who agreed to participate by signing an informed consent were included.

Exclusion Criteria:

Exclusion criteria included a diagnosis of Down syndrome, orthopedic disease or neurologic or diagnoses, history of acute heart attack, use of beta-blockers, any urgent or elective surgical intervention during the implementation of the protocol, those who used assistive devices to ambulate or develop an infectious process during the study protocol.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Ingen inngripen: Control Group (GC)
The GC received standard ambulatory care, including routine exams and drug therapy. All patients were reassessed after the 2 month protocol.
Eksperimentell: NMES Group (GE)
Receiving the usual care and guidance on their illness, underwent 30 minute NMES sessions twice a week for two months using an electrostimulator. Specifically, 5 cm adhesive surface electrodes in four alternate channels on the Rectus Femoris (two channels the right and two on the left) were used to deliver two-phase symmetrical currents, with a rectangular pulse wave at a frequency of 35 Hz and pulse duration of 250 μ. The time of ascent and descent was one second, contraction time was four seconds and relaxation was eight seconds.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Distance in six-minute walk test
Tidsramme: change from baseline in distance at 2 months
analysis of distance
change from baseline in distance at 2 months
Oxygen saturation in six-minute walk test
Tidsramme: change from baseline in oxygen saturation at 2 months
analysis of oxygen saturation at end of test
change from baseline in oxygen saturation at 2 months
Systolic blood pressure in six-minute walk test
Tidsramme: change from baseline in systolic blood pressure at 2 months
analysis of systolic blood pressure at end of test
change from baseline in systolic blood pressure at 2 months
Diastolic blood pressure in six-minute walk test
Tidsramme: change from baseline in diastolic blood pressure at 2 months
analysis of diastolic blood pressure at end of test
change from baseline in diastolic blood pressure at 2 months
Heart rate in six-minute walk test
Tidsramme: change from baseline in heart rate at 2 months
analysis of heart rate at end of test
change from baseline in heart rate at 2 months
Borg scale in six-minute walk test
Tidsramme: change from baseline in Borg scale at 2 months
analysis of Borg scale at end of test
change from baseline in Borg scale at 2 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
The Medical Outcomes Study 36-item Short Form Health Survey
Tidsramme: change from baseline at 2 months
The questionnaire covers 36 items, designed to assess health concepts
change from baseline at 2 months
Forced vital capacity
Tidsramme: change from baseline at 2 months
spirometric analysis
change from baseline at 2 months
Forced expiratory volume in the first second
Tidsramme: change from baseline at 2 months
spirometric analysis
change from baseline at 2 months
Forced expiratory flow 25-75 %
Tidsramme: change from baseline at 2 months
spirometric analysis
change from baseline at 2 months
Ratio of forced expiratory volume in the first second and forced vital capacity
Tidsramme: change from baseline at 2 months
spirometric analysis
change from baseline at 2 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. juni 2014

Primær fullføring (Faktiske)

1. juni 2016

Studiet fullført (Faktiske)

1. desember 2016

Datoer for studieregistrering

Først innsendt

8. mars 2016

Først innsendt som oppfylte QC-kriteriene

14. mars 2016

Først lagt ut (Anslag)

18. mars 2016

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. november 2019

Siste oppdatering sendt inn som oppfylte QC-kriteriene

14. november 2019

Sist bekreftet

1. februar 2016

Mer informasjon

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere